TBH Global Co., Ltd (KRX:084870)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2017
Market Capitalization	27,601	25,404	36,979	34,205	47,032	163,935
Market Cap Growth	-32.54%	-31.30%	8.11%	-27.27%	-71.31%	-9.65%
Enterprise Value	53,702	49,641	66,030	61,346	154,817	213,284
Last Close Price	1338.00	1174.11	1659.40	1494.65	2055.15	7163.39
PE Ratio	-	-	5.49	6.94	-	-
Forward PE	-	4.34	4.34	4.34	4.34	6.52
PS Ratio	0.15	0.14	0.19	0.17	0.25	0.24
PB Ratio	0.46	0.41	0.59	0.57	0.86	0.72
P/TBV Ratio	0.48	0.42	0.60	0.57	0.87	1.13
P/FCF Ratio	7.66	9.10	5.33	-	2.74	8.97
P/OCF Ratio	3.80	3.91	3.52	-	2.38	3.20
EV/Sales Ratio	0.30	0.28	0.34	0.30	0.82	0.31
EV/EBITDA Ratio	6.70	4.97	4.86	7.72	12.69	3.97
EV/EBIT Ratio	46.59	14.77	8.40	31.34	29.00	10.47
EV/FCF Ratio	14.91	17.79	9.51	-	9.02	11.67
Debt / Equity Ratio	0.46	0.38	0.41	0.42	0.67	0.26
Debt / EBITDA Ratio	3.40	2.39	1.92	3.19	2.99	1.09
Debt / FCF Ratio	7.56	8.54	3.76	-	2.12	3.19
Asset Turnover	1.63	1.65	1.77	1.77	-	1.25
Inventory Turnover	1.38	1.44	1.49	1.68	-	1.15
Quick Ratio	0.35	0.43	0.56	0.45	0.43	0.57
Current Ratio	1.75	2.01	2.07	1.80	1.37	1.35
Return on Equity (ROE)	-3.23%	-1.12%	10.93%	8.58%	-	0.42%
Return on Assets (ROA)	0.66%	1.95%	4.42%	1.07%	-	2.28%
Return on Capital (ROIC)	0.84%	2.40%	5.63%	1.39%	-	4.29%
Return on Capital Employed (ROCE)	1.70%	4.80%	10.90%	3.00%	7.90%	7.80%
Earnings Yield	-7.49%	-2.85%	18.22%	14.41%	-41.72%	-0.61%
FCF Yield	13.05%	10.99%	18.77%	-30.42%	36.51%	11.15%
Dividend Yield	2.91%	3.41%	-	-	-	-
Payout Ratio	-	-	15.48%	-	-	-
Buyback Yield / Dilution	-0.12%	-	-	-0.03%	5.73%	-5.71%
Total Shareholder Return	2.79%	3.41%	-	-0.03%	5.73%	-5.71%

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.